HUT61743A - Process for producing 2-(piperidin-1-yl)-ethanol derivatives and pharmaceutical compositions comprising such compounds as active ingredient - Google Patents
Process for producing 2-(piperidin-1-yl)-ethanol derivatives and pharmaceutical compositions comprising such compounds as active ingredientInfo
- Publication number
- HUT61743A HUT61743A HU9202138A HU9202138A HUT61743A HU T61743 A HUT61743 A HU T61743A HU 9202138 A HU9202138 A HU 9202138A HU 9202138 A HU9202138 A HU 9202138A HU T61743 A HUT61743 A HU T61743A
- Authority
- HU
- Hungary
- Prior art keywords
- piperidin
- compounds
- producing
- active ingredient
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9107936A FR2678270B1 (fr) | 1991-06-27 | 1991-06-27 | Derives de 2-(piperidin-1-yl)ethanol, leur preparation et leur application en therapeutique. |
FR9107934A FR2678265B1 (fr) | 1991-06-27 | 1991-06-27 | Derives de 4-(2-phenylethyl)piperidine, leur preparation et leur application en therapeutique. |
FR9204507A FR2689891B3 (fr) | 1992-04-13 | 1992-04-13 | Derives de 2-(piperidin-1-yl)ethanol, leur preparation et leur application en therapeutique. |
Publications (2)
Publication Number | Publication Date |
---|---|
HU9202138D0 HU9202138D0 (en) | 1992-10-28 |
HUT61743A true HUT61743A (en) | 1993-03-01 |
Family
ID=27252473
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9202138A HUT61743A (en) | 1991-06-27 | 1992-06-26 | Process for producing 2-(piperidin-1-yl)-ethanol derivatives and pharmaceutical compositions comprising such compounds as active ingredient |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0524846A1 (hu) |
JP (1) | JPH05186460A (hu) |
KR (1) | KR930000505A (hu) |
CN (1) | CN1069491A (hu) |
AU (1) | AU644296B2 (hu) |
CA (1) | CA2072520A1 (hu) |
CZ (1) | CZ199992A3 (hu) |
FI (1) | FI922979A (hu) |
HU (1) | HUT61743A (hu) |
IE (1) | IE922090A1 (hu) |
IL (1) | IL102334A0 (hu) |
MX (1) | MX9203452A (hu) |
NO (1) | NO922521L (hu) |
NZ (1) | NZ243337A (hu) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU4566093A (en) * | 1992-07-08 | 1994-01-31 | Shell Internationale Research Maatschappij B.V. | Piperidine derivatives |
WO1994010166A1 (en) * | 1992-10-30 | 1994-05-11 | Pfizer Inc. | Neuroprotective 3,4-dihydro-2(1h)-quinolone compounds |
FR2727864B1 (fr) * | 1994-12-12 | 1997-04-04 | Synthelabo | Utilisation des ligands des sites de liaison peripherique pour les benzodiazepines pour la preparation de medicaments utiles dans le traitement des neuropathies peripheriques |
ZA9610745B (en) * | 1995-12-22 | 1997-06-24 | Warner Lambert Co | 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
ZA9610741B (en) | 1995-12-22 | 1997-06-24 | Warner Lambert Co | 4-Substituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
ZA9610738B (en) | 1995-12-22 | 1997-06-24 | Warner Lambert Co | Subtype selective nmda receptor ligands and the use thereof |
ZA9610736B (en) * | 1995-12-22 | 1997-06-27 | Warner Lambert Co | 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists |
WO1999058117A1 (fr) * | 1998-05-13 | 1999-11-18 | Sanofi-Synthelabo | Utilisation de composes reduisant l'apoptose |
FR2778564B1 (fr) * | 1998-05-13 | 2001-07-13 | Sanofi Sa | Utilisation de composes reduisant l'apoptose |
EP1140107B1 (en) | 1998-12-18 | 2006-07-19 | Scios Inc. | Agonists and antagonists of peripheral-type benzodiazepine receptors |
US20070185168A1 (en) * | 2004-04-07 | 2007-08-09 | Takai Haruki S | Piperidine derivatives |
CN103896835A (zh) * | 2014-04-20 | 2014-07-02 | 武汉珈瑜科技有限公司 | 喹啉酮类衍生物及其应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1030415A (zh) * | 1987-02-20 | 1989-01-18 | 山之内制药株式会社 | 饱和的杂环碳酰胺衍生物和它的制备方法 |
FR2640266B2 (fr) * | 1988-07-12 | 1992-07-10 | Synthelabo | Derives de (hydroxy-1 piperidinyl-2 alkyl) indolones-2, quinoleinones-2, benzo(b)azepinones-2 et benzimidazolones-2, leur preparation et leur application en therapeutique |
JP2969359B2 (ja) * | 1989-01-13 | 1999-11-02 | 武田薬品工業株式会社 | 環状アミン化合物 |
FR2644786B1 (fr) * | 1989-03-21 | 1993-12-31 | Adir Cie | Nouveaux derives fluoro-4 benzoiques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent |
JPH03130263A (ja) * | 1989-07-19 | 1991-06-04 | Eisai Co Ltd | 光学活性ナフチルエタノール誘導体 |
FR2668149B1 (fr) * | 1990-10-18 | 1994-09-23 | Synthelabo | Le 1-(3,4-dihydro-2-oxo-1h-quinolein-6-yl)-2-[4-(2-phenyl-ethyl)piperidin-1-yl]ethanol, sa preparation et son application en therapeutique. |
-
1992
- 1992-06-24 EP EP92401769A patent/EP0524846A1/fr not_active Withdrawn
- 1992-06-25 KR KR1019920011122A patent/KR930000505A/ko not_active Application Discontinuation
- 1992-06-26 IL IL102334A patent/IL102334A0/xx unknown
- 1992-06-26 NO NO92922521A patent/NO922521L/no unknown
- 1992-06-26 HU HU9202138A patent/HUT61743A/hu unknown
- 1992-06-26 FI FI922979A patent/FI922979A/fi unknown
- 1992-06-26 JP JP4168943A patent/JPH05186460A/ja active Pending
- 1992-06-26 AU AU18589/92A patent/AU644296B2/en not_active Ceased
- 1992-06-26 NZ NZ243337A patent/NZ243337A/en unknown
- 1992-06-26 CZ CS921999A patent/CZ199992A3/cs unknown
- 1992-06-26 MX MX9203452A patent/MX9203452A/es unknown
- 1992-06-26 CA CA002072520A patent/CA2072520A1/en not_active Abandoned
- 1992-06-26 CN CN92105067A patent/CN1069491A/zh active Pending
- 1992-07-01 IE IE209092A patent/IE922090A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
HU9202138D0 (en) | 1992-10-28 |
FI922979A (fi) | 1992-12-28 |
MX9203452A (es) | 1994-01-31 |
KR930000505A (ko) | 1993-01-15 |
NO922521L (no) | 1992-12-28 |
AU1858992A (en) | 1993-01-07 |
JPH05186460A (ja) | 1993-07-27 |
EP0524846A1 (fr) | 1993-01-27 |
CZ199992A3 (en) | 1993-01-13 |
IE922090A1 (en) | 1992-12-30 |
NZ243337A (en) | 1994-03-25 |
IL102334A0 (en) | 1993-01-14 |
CN1069491A (zh) | 1993-03-03 |
AU644296B2 (en) | 1993-12-02 |
NO922521D0 (no) | 1992-06-26 |
CA2072520A1 (en) | 1992-12-28 |
FI922979A0 (fi) | 1992-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUT59106A (en) | Process for producing 3-amidopyrazoles and pharmaceutical compositions comprising such compounds as active ingredient | |
HUT59145A (en) | Process for producing substituted azole derivatives and pharmaceutical compositions such compounds as active ingredient | |
HUT52089A (en) | Process for producing triazole derivatives and pharmaceutical compositions comprising such compounds as active ingredient | |
HUT56270A (en) | Process for producing taxol derivatives and pharmaceutical compositions comprising such active ingredient | |
HUT61751A (en) | Process for producing benzofuran derivatives and pharmaceutical compositions comprising such compounds as active ingredient | |
HUT64065A (en) | Process for producing quinolone- and naphthyridonecarboxylic acid derivatives and pharmaceutical compositions comprising same as active ingredient | |
HUT60466A (en) | Process for producing amino acid derivatives and pharmaceutical compositions comprising such active ingredient | |
HUT56361A (en) | Process for producing new triazole derivatives and pharmaceutical compositions comprising such compounds | |
HUT61298A (en) | Process for producing bicyclic heterocyclic compounds and pharmaceutical composition comprising same as active ingredient | |
HUT49625A (en) | Process for producing macrolid compounds and pharmaceutical compositions comprising such active ingredient | |
HUT64013A (en) | Process for producing hiv-inhibiting phenylacetamide derivatives and pharmaceutical compositions comprising such compounds as active ingredient | |
HUT53098A (en) | Process for producing 2-(1-piperazinyl)-4-phenylcycloalkanepyrimidine derivatives and pharmaceutical compositions comprising such compounds | |
HUT59389A (en) | Process for producing heterocyclic compounds and pharmaceutical compositions comprising same | |
HUT54139A (en) | Process for producing n-heteroaryl-4-quinolineamine derivatives and pharmaceutical compositions comprising such compounds | |
HUT62003A (en) | Process for producing 1,3-benzoxazine derivatives and pharmaceutical compositions comprising such compounds | |
HUT61743A (en) | Process for producing 2-(piperidin-1-yl)-ethanol derivatives and pharmaceutical compositions comprising such compounds as active ingredient | |
HUT60486A (en) | Process for producing condensed heterocyclic compounds and pharmaceutical compositions comprising such compounds | |
HUT53897A (en) | Process for producing benzopyran derivatives and pharmaceutical compositions comprising such compounds as active ingredient | |
HUT56359A (en) | Process for producing leukotriene antagonist compounds and pharmaceutical compositions comprising same as active ingredient | |
HUT62593A (en) | Process for producing 3-deoxymannose amine derivatives and pharmaceutical compositions comprising such active ingredient | |
HUT59116A (en) | Process for producing oxazole derivatives and pharmaceutical compositions comprising oxazole derivatives as active ingredient | |
HUT58082A (en) | Process for producing chroman derivatives and pharmaceutical compositions comprising such compounds as active ingredient | |
HUT63415A (en) | Process for producing heterocyclic imidazole derivatives and pharmaceutical compositions comprising same as active ingredient | |
HUT57770A (en) | Process for producing new 2-(substituted alkyl)-3-carboxy-carbapenem-carboxylic acid derivatives and pharmaceutical compositions comprising such compounds and having antibiotic effect | |
HUT61548A (en) | Process for producing indolonaphthyridine derivatives and pharmaceutical compositions comprising such compounds |